Genscript Biotech Co. (OTCMKTS:GNNSF) Short Interest Update

Genscript Biotech Co. (OTCMKTS:GNNSF) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 6,386,400 shares, a decrease of 6.0% from the September 15th total of 6,791,800 shares. Based on an average trading volume of 1,800 shares, the short-interest ratio is presently 3,548.0 days.

Genscript Biotech Price Performance

GNNSF remained flat at C$1.40 on Wednesday. The company’s stock had a trading volume of 2,000 shares, compared to its average volume of 78,089. Genscript Biotech has a fifty-two week low of C$1.05 and a fifty-two week high of C$3.20. The firm’s fifty day moving average price is C$1.48 and its 200-day moving average price is C$1.44.

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.